Bio-Rad Laboratories (NYSE:BIO.B) Stock Price Down 17.3%

Bio-Rad Laboratories, Inc. (NYSE:BIO.B)’s share price traded down 17.3% during trading on Friday . The company traded as low as $279.91 and last traded at $279.91. 400 shares were traded during mid-day trading, a decline of 66% from the average session volume of 1,193 shares. The stock had previously closed at $338.55.

Bio-Rad Laboratories Trading Down 0.3 %

The company has a debt-to-equity ratio of 0.14, a quick ratio of 4.34 and a current ratio of 5.83. The stock has a market cap of $7.96 billion, a PE ratio of -13.03 and a beta of 0.66. The stock has a fifty day moving average price of $328.95 and a 200 day moving average price of $318.44.

Bio-Rad Laboratories (NYSE:BIO.B) last issued its quarterly earnings results on Thursday, February 15th. The company reported $3.10 earnings per share (EPS) for the quarter. Bio-Rad Laboratories had a positive return on equity of 3.90% and a negative net margin of 23.86%. The firm had revenue of $681.18 million during the quarter.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.